Agilent Technologies Inc (A)
148.06
+1.32
(+0.90%)
USD |
NYSE |
Sep 27, 16:00
148.13
+0.07
(+0.05%)
After-Hours: 20:00
Agilent Technologies SG&A Expense (Annual): 1.634B for Oct. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
October 31, 2023 | 1.634B |
October 31, 2022 | 1.637B |
October 31, 2021 | 1.619B |
October 31, 2020 | 1.496B |
October 31, 2019 | 1.46B |
October 31, 2018 | 1.389B |
October 31, 2017 | 1.251B |
October 31, 2016 | 1.253B |
October 31, 2015 | 1.189B |
October 31, 2014 | 1.199B |
October 31, 2013 | 1.184B |
October 31, 2012 | 1.817B |
October 31, 2011 | 1.809B |
Date | Value |
---|---|
October 31, 2010 | 1.752B |
October 31, 2009 | 1.603B |
October 31, 2008 | 1.697B |
October 31, 2007 | 1.70B |
October 31, 2006 | 1.66B |
October 31, 2005 | 1.498B |
October 31, 2004 | 1.502B |
October 31, 2003 | 1.784B |
October 31, 2002 | 2.754B |
October 31, 2001 | 3.004B |
October 31, 2000 | 2.786B |
October 31, 1999 | 1.902B |
October 31, 1998 | 2.05B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.46B
Minimum
2019
1.637B
Maximum
2022
1.569B
Average
1.619B
Median
2021
SG&A Expense (Annual) Benchmarks
Avantor Inc | 1.507B |
Bio-Rad Laboratories Inc | 841.72M |
Revvity Inc | 1.023B |
Bruker Corp | 730.10M |
Azenta Inc | 316.28M |